Final answer:
When a patient is receiving neomycin for the treatment of hepatic encephalopathy, it is vital to evaluate renal function studies daily. This monitoring is critical to prevent neomycin-induced nephrotoxicity, as the patient might already be at risk for kidney dysfunction.
Step-by-step explanation:
The patient in question is receiving neomycin for the treatment of hepatic encephalopathy, a condition often associated with liver failure which presents as a neuropsychiatric abnormality. Neomycin can be nephrotoxic, and given that the patient's condition may already predispose them to kidney dysfunction, it is crucial to monitor renal function closely. Therefore, the answer to the question is a.evaluate renal function studies daily.
This daily assessment of the patient's renal function may involve monitoring kidney function tests, such as serum creatinine and blood urea nitrogen (BUN) levels, to ensure that neomycin is not causing nephrotoxicity. Regular monitoring is essential because impaired kidney function can lead to the accumulation of neomycin and potentially more serious toxicity.
Dosage and route of administration should be carefully calibrated, especially in patients with existing liver or kidney dysfunction, to avoid adverse effects and toxicity. Fluids, electrolyte replacements, and supportive therapy may also be critical in the supportive care for the patient.